Clinical Trial Update: Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing how latent tuberculosis infection treatment affects glucose tolerance and chronic inflammation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Herlev and Gentofte Hospital | Conditions: Latent Tuberculosis, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED